News

TMA Registry name change

In February 2021 the process was started to change the name of the registry from Thrombotic Thrombocytopenic Purpura Registry incorporating Thrombotic Microangiopathies to the Thrombotic Microangiopathies (TMA) Registry.

The name change, along with an updated protocol and participant brochure, is currently being submitted to Lead Human Research Ethics Committees (HRECs). Once approved, it will be submitted to site governance offices.

If you have any questions about the name change, please contact the TMA Registry Coordinator.